文献速递血栓与止血

遗传风险与中老年人接种COVID-19疫苗后新发静脉血栓栓塞症

Genetic risk and incident venous thromboembolism in middle-aged and older adults following COVID-19 vaccination.
PubMed 文献 · J Thromb Haemost · 2022-10-05

基于英国生物银行359310名接种一剂COVID-19疫苗者,使用299个遗传变异构建多基因风险评分(PRS),前瞻性评估PRS与新发VTE的关联。随访28天和90天分别有88和299人发生VTE,PRS每增加1个标准差,28天VTE风险HR 1.41(95%CI 1.15-1.73),90天HR 1.36(95%CI 1.22-1.52),与历史未接种队列相似。

要点

  • 接种COVID-19疫苗后28天和90天VTE发生率分别为0.88和0.92每10万人日。
  • PRS每增加1个标准差,28天VTE风险HR 1.41(95%CI 1.15-1.73),90天HR 1.36(95%CI 1.22-1.52)。
  • PRS与VTE的关联在腺病毒和mRNA疫苗中等效,且与历史未接种队列相似。

核心结论

  • 遗传易感性对COVID-19疫苗接种后VTE的影响强度与历史数据相似。
  • 观察到的PRS-VTE关联在腺病毒和mRNA疫苗中等效。
  • 这些发现提示,在人群水平上,COVID-19疫苗接种后发生的VTE与常规VTE具有相似的遗传病因。

研究设计与样本

  • 利用英国生物银行数据,包含深度基因分型和关联的疫苗接种及健康结局信息。
  • 使用299个遗传变异生成多基因风险评分(PRS)。
  • 前瞻性评估PRS与首剂和次剂疫苗接种后新发VTE的关联,并在大流行前和早期未接种历史队列中评估。
  • 使用Cox模型估计PRS-VTE关联的风险比(HR)。
  • 359310名接种一剂COVID-19疫苗者中,160327(44.6%)为男性,接种日期平均年龄69.05(标准差8.04)岁。

主要发现

  • 随访28天和90天后,分别有88和299人发生VTE,相当于发生率0.88(95%CI 0.70-1.08)和0.92(95%CI 0.82-1.04)每10万人日。
  • PRS与VTE风险升高显著相关:PRS每增加1个标准差,28天HR 1.41(95%CI 1.15-1.73),90天HR 1.36(95%CI 1.22-1.52)。
  • 在历史未接种队列中也发现相似的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COVID-19 vaccination has been associated with increased venous thromboembolism (VTE) risk. However, it is unknown whether genetic predisposition to VTE is associated with an increased risk of thrombosis following vaccination. METHODS: Using data from the UK Biobank, which contains in-depth genotyping and linked vaccination and health outcomes information, we generated a polygenic risk score (PRS) using 299 genetic variants. We prospectively assessed associations between PRS and incident VTE immediately after first- and the second-dose vaccination and among historical unvaccinated cohorts during the pre- and early pandemic. We estimated hazard ratios (HR) for PRS-VTE associations using Cox models. RESULTS: Of 359 310 individuals receiving one dose of a COVID-19 vaccine, 160 327 (44.6%) were males, and the mean age at the vaccination date was 69.05 (standard deviation [SD] 8.04) years. After 28- and 90-days' follow-up, 88 and 299 individuals developed VTE, respectively, equivalent to an incidence rate of 0.88 (95% confidence interval [CI] 0.70-1.08) and 0.92 (0.82-1.04) per 100 000 person-days. The PRS was significantly associated with a higher risk of VTE (HR per 1 SD increase in PRS, 1.41 (1.15-1.73) in 28 days and 1.36 (1.22-1.52) in 90 days). Similar associations were found in the historical unvaccinated cohorts. CONCLUSIONS: The strength of genetic susceptibility with post-COVID-19-vaccination VTE is similar to that seen in historical data. Additionally, the observed PRS-VTE associations were equivalent for adenovirus- and mRNA-based vaccines. These findings suggest that, at the population level, the VTE that occurred after the COVID-19 vaccination has a similar genetic etiology to the conventional VTE.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Xie J, Prats-Uribe A, Gordillo-Marañón M, et al. Genetic risk and incident venous thromboembolism in middle-aged and older adults following COVID-19 vaccination. J Thromb Haemost. 2022. PMID: 36111372. doi:10.1111/jth.15879

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。